The 2019 edition of the International Neurotoxin Association Conference (Toxins 2019) was recently held in Copenhagen, Denmark and was extremely well attended and received with more than 1,400 participants from 61 countries. The scientific programme featured top speakers, stimulating discussions, and scientific breakthroughs. The articles presented in this conference report provide a very good overview of the plenaries and workshops and cover major innovative developments in basic sciences, clinical research, and treatment applications in the field of botulinum toxins. More specifically, the topics presented in this report include the well established use of botulinum toxins in spasticity and cervical dystonia with emphasis on recent clinical trials and treatment algorithms, the more recently establish...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Patients with keloids carry an increased cancer risk Next Article
Combination treatment of AK: Thicker lesions benefit from laser pretreatment with high channel density »
Table of Contents: TOXINS 2019
New Versions of Botulinum Toxins
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.